PROVIDER PROFILE · NPI 1952503542

Peter Vanburen

PRACTICEUT SOUTHWESTERNSee all providers at this practice →

NephrologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$544

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Carvedilol13 claims

Losartan Potassium13 claims

Hydralazine Hcl11 claims

QUALITY · MIPS · 2024

Final MIPS score

82.9

Quality

70.2

Cost

72.8

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.33%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Peter Vanburen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS	68	575
UT SOUTHWESTERN DVA HEALTHCARE LLP	28	571
Ravindra Sarode Pathology · Dallas, TX	14	53
BAYLOR UNIVERSITY MEDICAL CENTER	12	58
TASIAN, BERGE	11	33

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history